Back to mobile site

Haemonetics (HAE) Tops Q1 EPS by 2c

August 7, 2017 6:02 AM EDT

Haemonetics (NYSE: HAE) reported Q1 EPS of $0.33, $0.02 better than the analyst estimate of $0.31. Revenue for the quarter came in at $211 million versus the consensus estimate of $212.12 million.

For earnings history and earnings-related data on Haemonetics (HAE) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings